Source link : https://www.newshealth.biz/health-news/drug-therapy-continues-to-offer-little-benefit/
SAVANNAH, GEORGIA — Current disease-modifying therapies for amyotrophic lateral sclerosis (ALS) don’t extend lifespans by much, but several drug options are available, nerve specialists learned. The glutamate blocker riluzole (Rilutek), which became the first ALS drug to receive US Food and Drug Administration (FDA) approval in 1995, continues to be used, said Michael D. Weiss, […]
Author : News Health
Publish date : 2024-10-21 12:54:04
Copyright for syndicated content belongs to the linked Source.